Madelynn N Whittaker

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Pseudomonas Aeruginosa

Top Venues

Science (New York, N.Y.)

Arteriosclerosis, thrombosis, and vascular biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Madelynn N Whittaker, Lauren C Testa, Aidan Quigley, Ishaan Jindal, Saúl V Cortez-Alvarado, Ping Qu, Yifan Yang, Mohamad Gabriel Alameh, Kiran Musunuru, Xiao Wang
Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes. Arteriosclerosis, thrombosis, and vascular biology (2023)
Yong Tao, Veronica Lamas, Wan Du, Wenliang Zhu, Yiran Li, Madelynn N Whittaker, John A Zuris, David B Thompson, Arun Prabhu Rameshbabu, Yi-Lai Shu, Xue Gao, Johnny H Hu, Charles Pei, Wei-Jia Kong, Xuezhong Liu, Hao Wu, Benjamin P Kleinstiver, David R Liu, Zheng-Yi Chen
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo. Nature communications 14 (1) (2023)
Russell T Walton, Kathleen A Christie, Madelynn N Whittaker, Benjamin P Kleinstiver
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science (New York, N.Y.) 368 (6488) (2020)